Biotechnology Stocks
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 119 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 503.39 USD | -0.44% | -0.66% | -3.93% | +20.05% | 127.59 B USD | ||
| 211 |  MRNA Moderna, Inc. - Common Stock | 197.20 USD | +0.37% | +4.38% | +40.56% | +603.78% | 78.73 B USD | ||
| 218 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 739.50 USD | -0.35% | +0.64% | -8.00% | +29.96% | 76.14 B USD | ||
| 306 |  ARGX argenx SE - American Depositary Shares | 817.80 USD | -11.92% | -12.63% | -17.53% | +2.67% | 50.61 B USD | ||
| 369 |  RVMD Revolution Medicines, Inc. - Common Stock | 188.10 USD | -6.36% | -8.64% | -8.69% | +239.53% | 40.32 B USD | ||
| 446 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 224.53 USD | +0.05% | -2.82% | -12.46% | -50.22% | 30.04 B USD | ||
| 506 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.21 USD | -0.97% | -2.46% | -7.24% | +50.86% | 25.10 B USD | ||
| 512 |  ROIV Roivant Sciences Ltd. - Common Shares | 34.23 USD | -1.50% | -3.58% | -17.30% | +86.95% | 24.73 B USD | ||
| 530 |  INCY Incyte Corporation - Common Stock | 112.73 USD | -0.63% | -3.76% | -9.38% | +31.77% | 22.85 B USD | ||
| 531 |  UTHR United Therapeutics Corporation - Common Stock | 532.78 USD | -2.24% | -6.76% | +6.99% | +18.44% | 22.85 B USD | ||
| 539 |  BNTX BioNTech SE - American Depositary Shares | 92.06 USD | -3.35% | -4.89% | -6.54% | -13.34% | 22.09 B USD | ||
| 551 |  INSM Insmed Incorporated - Common Stock | 100.61 USD | -1.11% | -7.29% | -18.86% | -37.91% | 21.97 B USD | ||
| 684 |  EXEL Exelixis, Inc. - Common Stock | 59.02 USD | +0.99% | +1.86% | +2.64% | +51.18% | 14.62 B USD | ||
| 700 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 222.45 USD | -3.78% | -4.53% | -6.70% | +58.89% | 14.44 B USD | ||
| 711 |  ASND Ascendis Pharma A/S - American Depositary Shares | 222.63 USD | -2.53% | -1.93% | -17.15% | +8.56% | 13.80 B USD | ||
| 723 |  SMMT Summit Therapeutics Inc. - Common Stock | 17.18 USD | -4.29% | +3.00% | -5.29% | -13.49% | 13.71 B USD | ||
| 752 |  CORT Corcept Therapeutics Incorporated - Common Stock | 118.54 USD | -0.89% | +3.96% | +3.80% | +61.56% | 12.81 B USD | ||
| 766 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 65.04 USD | -2.20% | -2.79% | -11.67% | +14.11% | 12.71 B USD | ||
| 778 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 109.86 USD | -0.84% | +2.73% | +2.20% | +64.46% | 12.47 B USD | ||
| 822 |  TECH Bio-Techne Corp - Common Stock | 72.47 USD | -0.08% | +0.08% | +0.24% | +19.67% | 11.36 B USD |
뉴스 Biotechnology Stocks
RBC 캐피털, 리듬 파마슈티컬스에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 159달러로 상향
RBC 캐피털, 엑셀리시스 투자의견 ‘시장수익률’ 유지·목표주가 45달러로 하향
ADC 테라퓨틱스, 주당 1.42달러에 1,290만 주 및 주당 1.32달러에 4,810만 주 매입 워런트 제공하는 8,660만 달러 규모 파이프 파이낸싱 발표; 대출 및 로열티 수정 확보
뉴트리밴드, AVERSA 남용 억제 경피 기술 보호 강화 위해 미국 특허 출원
바이오라인RX, GLIX1 관련 초록 2편이 11월 12~15일 신경종양학회 연례회의에서 발표될 예정이라고 발표
아트리움 테라퓨틱스, 5,170,384주 및 사전 자금 조달 워런트 최대 1,134,930주 매입을 위한 약 7.93달러/주당 5천만 달러 규모의 사모 발표
러시아, 시베리아에서 두 번째 발병 사례 보도 부인 - 블룸버그
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |